CN1052666A - 1-苯基-咪唑啉-2,5-二酮衍生物的制备方法 - Google Patents
1-苯基-咪唑啉-2,5-二酮衍生物的制备方法 Download PDFInfo
- Publication number
- CN1052666A CN1052666A CN90110071A CN90110071A CN1052666A CN 1052666 A CN1052666 A CN 1052666A CN 90110071 A CN90110071 A CN 90110071A CN 90110071 A CN90110071 A CN 90110071A CN 1052666 A CN1052666 A CN 1052666A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- catalyzer
- phenyl
- triglyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Photoreceptors In Electrophotography (AREA)
- Reinforced Plastic Materials (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8917046A FR2656302B1 (fr) | 1989-12-22 | 1989-12-22 | Nouveau procede de preparation de l'anandron et derives de l'anandron. |
FR8917046 | 1989-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1052666A true CN1052666A (zh) | 1991-07-03 |
CN1048011C CN1048011C (zh) | 2000-01-05 |
Family
ID=9388859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN90110071A Expired - Lifetime CN1048011C (zh) | 1989-12-22 | 1990-12-22 | 1-苯基-咪唑啉-2,5-二酮衍生物的制备方法 |
Country Status (24)
Country | Link |
---|---|
US (1) | US5166358A (zh) |
EP (1) | EP0436426B1 (zh) |
JP (1) | JP2836041B2 (zh) |
KR (1) | KR0173307B1 (zh) |
CN (1) | CN1048011C (zh) |
AT (1) | ATE107289T1 (zh) |
AU (1) | AU628699B2 (zh) |
CA (1) | CA2032988C (zh) |
CZ (1) | CZ281655B6 (zh) |
DE (1) | DE69009964T2 (zh) |
DK (1) | DK0436426T3 (zh) |
ES (1) | ES2055382T3 (zh) |
FI (1) | FI103203B1 (zh) |
FR (1) | FR2656302B1 (zh) |
HU (1) | HU207301B (zh) |
IE (1) | IE65510B1 (zh) |
IL (1) | IL96696A (zh) |
NZ (1) | NZ236621A (zh) |
PL (1) | PL164694B1 (zh) |
PT (1) | PT96313B (zh) |
RU (1) | RU1836356C (zh) |
SK (1) | SK278447B6 (zh) |
UA (1) | UA27220C2 (zh) |
ZA (1) | ZA909648B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1131219C (zh) * | 1995-11-16 | 2003-12-17 | 赫斯特·马里恩·鲁索公司 | 苯基咪唑烷衍生物的新制备方法 |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2693461B1 (fr) * | 1992-07-08 | 1994-09-02 | Roussel Uclaf | Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
US5411981A (en) * | 1991-01-09 | 1995-05-02 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
FR2694290B1 (fr) * | 1992-07-08 | 1994-09-02 | Roussel Uclaf | Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
US5656651A (en) * | 1995-06-16 | 1997-08-12 | Biophysica Inc. | Androgenic directed compositions |
FR2741342B1 (fr) * | 1995-11-22 | 1998-02-06 | Roussel Uclaf | Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques |
JPH1072446A (ja) * | 1996-06-24 | 1998-03-17 | Sumitomo Chem Co Ltd | 1−置換−ヒダントイン類の製造法 |
EP1299094A2 (en) * | 2000-06-28 | 2003-04-09 | Bristol-Myers Squibb Company | Selective androgen receptor modulators and methods for their identification, design and use |
EP1854798A3 (en) | 2000-09-19 | 2007-11-28 | Bristol-Myers Squibb Company | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
US20040087548A1 (en) | 2001-02-27 | 2004-05-06 | Salvati Mark E. | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
ATE502298T1 (de) * | 2003-12-19 | 2011-04-15 | Univ California | Verfahren und materialien zur beurteilung von prostatakrebstherapien |
WO2005099693A2 (en) * | 2004-02-24 | 2005-10-27 | The Regents Of The University Of California | Methods and materials for assessing prostate cancer therapies and compounds |
US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
EP2656841B1 (en) * | 2006-03-27 | 2016-08-10 | The Regents of The University of California | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
CN102755318B (zh) | 2006-03-29 | 2014-09-10 | 加利福尼亚大学董事会 | 二芳基硫代乙内酰脲化合物 |
JP5535925B2 (ja) | 2007-10-26 | 2014-07-02 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | アンドロゲン受容体調節物質としてのジアリールヒダントイン化合物 |
SI3124481T1 (en) | 2010-02-16 | 2018-06-29 | Aragon Pharmaceuticals, Inc. | Androgen receptor modulators and their use |
SI3305285T1 (sl) | 2012-09-26 | 2021-03-31 | Aragon Pharmaceuticals, Inc. | Anti-androgeni za zdravljenje proti kastraciji odpornega ne-metastatskega raka |
JOP20200097A1 (ar) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
JP7201694B2 (ja) | 2017-10-16 | 2023-01-10 | アラゴン ファーマシューティカルズ,インコーポレイテッド | 非転移性去勢抵抗性前立腺癌の治療のための抗アンドロゲン剤 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH166004A (de) * | 1934-06-06 | 1933-12-15 | Chem Fab Vormals Sandoz | Verfahren zur Darstellung eines Derivates des 5,5-Phenyläthylhydantoins. |
US2490813A (en) * | 1944-11-29 | 1949-12-13 | Standard Oil Co | Continuous process for making aryl amines |
US2759002A (en) * | 1954-03-24 | 1956-08-14 | Abbott Lab | 3-benzyl hydantoin and process |
US3134663A (en) * | 1957-07-23 | 1964-05-26 | Geigy Chem Corp | Herbicidal composition and method employing hydantoins |
US3914311A (en) * | 1973-06-15 | 1975-10-21 | Du Pont | Preparation of aromatic secondary and tertiary amines using a nickel complex catalyst |
DE2414613A1 (de) * | 1974-03-26 | 1975-10-16 | Bayer Ag | 1-aryl-5-alkyliden-2,4-dioxo-imidazolidine |
FR2329276A1 (fr) * | 1975-10-29 | 1977-05-27 | Roussel Uclaf | Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant |
IL55774A (en) * | 1977-10-28 | 1982-04-30 | Sparamedica Ag | Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture |
GB1598166A (en) * | 1978-05-23 | 1981-09-16 | Lilly Industries Ltd | 3,5-disubstituted hydantoin derivatives |
US4764625A (en) * | 1980-12-12 | 1988-08-16 | Xerox Corporation | Process for preparing arylamines |
DE3382406D1 (de) * | 1982-04-08 | 1991-10-17 | Shell Int Research | Neue hydantoine, ihre herstellung und verwendung. |
-
1989
- 1989-12-22 FR FR8917046A patent/FR2656302B1/fr not_active Expired - Fee Related
-
1990
- 1990-11-16 IE IE414290A patent/IE65510B1/en not_active IP Right Cessation
- 1990-11-30 ZA ZA909648A patent/ZA909648B/xx unknown
- 1990-12-10 JP JP2407176A patent/JP2836041B2/ja not_active Expired - Lifetime
- 1990-12-17 IL IL9669690A patent/IL96696A/en not_active IP Right Cessation
- 1990-12-18 US US07/629,490 patent/US5166358A/en not_active Expired - Lifetime
- 1990-12-20 AU AU68265/90A patent/AU628699B2/en not_active Expired
- 1990-12-20 PL PL90288365A patent/PL164694B1/pl unknown
- 1990-12-21 AT AT90403725T patent/ATE107289T1/de not_active IP Right Cessation
- 1990-12-21 SK SK6567-90A patent/SK278447B6/sk not_active IP Right Cessation
- 1990-12-21 EP EP90403725A patent/EP0436426B1/fr not_active Expired - Lifetime
- 1990-12-21 DK DK90403725.6T patent/DK0436426T3/da active
- 1990-12-21 PT PT96313A patent/PT96313B/pt not_active IP Right Cessation
- 1990-12-21 NZ NZ236621A patent/NZ236621A/en unknown
- 1990-12-21 CZ CS906567A patent/CZ281655B6/cs not_active IP Right Cessation
- 1990-12-21 UA UA4894040A patent/UA27220C2/uk unknown
- 1990-12-21 ES ES90403725T patent/ES2055382T3/es not_active Expired - Lifetime
- 1990-12-21 HU HU908416A patent/HU207301B/hu unknown
- 1990-12-21 KR KR1019900021357A patent/KR0173307B1/ko not_active IP Right Cessation
- 1990-12-21 CA CA002032988A patent/CA2032988C/fr not_active Expired - Lifetime
- 1990-12-21 FI FI906366A patent/FI103203B1/fi active IP Right Grant
- 1990-12-21 RU SU904894040A patent/RU1836356C/ru active
- 1990-12-21 DE DE69009964T patent/DE69009964T2/de not_active Expired - Lifetime
- 1990-12-22 CN CN90110071A patent/CN1048011C/zh not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1131219C (zh) * | 1995-11-16 | 2003-12-17 | 赫斯特·马里恩·鲁索公司 | 苯基咪唑烷衍生物的新制备方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1048011C (zh) | 1-苯基-咪唑啉-2,5-二酮衍生物的制备方法 | |
CN114195711B (zh) | 一种喹啉-4(1h)-酮化合物的制备方法 | |
CN1051084C (zh) | N-9取代的鸟嘌呤化合物的制备 | |
CN1069629C (zh) | α,β-不饱和有机羧酸的制备方法 | |
CN1019911C (zh) | 新的苯并嗪衍生物的制备方法 | |
CN1197864C (zh) | 吡唑并哒嗪衍生物的制备方法 | |
CN1030389C (zh) | 制备1,5-苯并硫氮杂䓬衍生物的方法 | |
CN1019495B (zh) | 嘧啶衍生物的制备方法 | |
JPS58189132A (ja) | ブテン誘導体の製造方法 | |
CN1407981A (zh) | 通过过渡金属催化的氨基化反应制备5-(1-哌嗪基)-苯并呋喃-2-甲酰胺的方法 | |
WO1988005772A1 (en) | Process for preparing tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxymethyl)methane | |
CN1078466A (zh) | 具有心血管作用的苯并嗪酮和苯并噻嗪酮 | |
CN1137085C (zh) | 制备5,6-二羟基-2-氨基-1,2,3,4-四氢化萘的方法 | |
JPH0517214B2 (zh) | ||
CN101006044A (zh) | 对苯二甲醛的提纯方法 | |
CN1228093A (zh) | 7-烷氧烷基-1,2,4-三唑并[1,5-a]嘧啶衍生物的制备方法 | |
CN1084742C (zh) | 3-苯基-1-亚甲二氧基苯基-1,2-二氢化茚-2-羧酸衍生物的制备方法 | |
CN1605391A (zh) | 高分子负载的全氟烷基磺酸和磺酸盐、制备方法及其应用 | |
CN1264362A (zh) | 制备4-(烷基)-3-烷氧基-苯胺型化合物的方法 | |
CN1026586C (zh) | 新的噻唑烷酮衍生物制备方法 | |
JPS63290838A (ja) | ベンジルオキシフェノン類の製造法 | |
CN85103245A (zh) | 手性铑-二膦络合物的制备及其在不对称加氢中的应用 | |
CN1032003A (zh) | 苯氧基烷基羧酸衍生物及其制备方法 | |
CN1656047A (zh) | 富集了对映异构体的化合物的制备方法 | |
KR800000813B1 (ko) | 몰포리논 유도체의 제조법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C15 | Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993) | ||
OR01 | Other related matters | ||
C56 | Change in the name or address of the patentee |
Owner name: LUSUO ROUSSEL UCLAF CO., LTD. Free format text: FORMER NAME OR ADDRESS: ROUSSEL-UCLAF Owner name: VENTIS PHARMA S.A. Free format text: FORMER NAME OR ADDRESS: HOECHST MARION ROUSSEL INC. Owner name: HOECHST MARION ROUSSEL INC. Free format text: FORMER NAME OR ADDRESS: LUSUO ROUSSEL UCLAF CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: French Anthony Patentee after: AVENTIS PHARMA S.A. Address before: French AUX Patentee before: Hoechst Marion Roussel Address after: French Roman Patentee after: Roussel-Uclaf Address before: Paris France Patentee before: ROUSSEL UCLAF Address after: French AUX Patentee after: Hoechst Marion Roussel Address before: French Roman Patentee before: Roussel-Uclaf |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20101222 Granted publication date: 20000105 |